Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-02-17 | Mr. Gregg RussoChief HR Officer | 476,00 | 0,00 | Derivative Exercise and Retained Stock | - | 476,00 | - |
| 2026-02-17 | Mr. Gregg RussoChief HR Officer | -211,00 | 0,00 | Derivative Exercise and Sale | - | 476,00 | - |
| 2026-01-05 | Mr. Richard John DalyPresident, CEO & Director | 31,53k | 0,00 | Derivative Exercise and Retained Stock | - | 271,27k | 13,15% |
| 2026-01-05 | Mr. Richard John DalyPresident, CEO & Director | -10,58k | 0,00 | Derivative Exercise and Sale | - | 271,27k | - |
| 2026-01-05 | Mr. Michael W. KalbExec. VP, Treasurer & CFO | 5,06k | 0,00 | Derivative Exercise and Retained Stock | - | 13,67k | 58,78% |
| 2026-01-05 | Mr. Michael W. KalbExec. VP, Treasurer & CFO | -2,08k | 0,00 | Derivative Exercise and Sale | - | 13,67k | - |
| 2025-12-29 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | 4,83k | 0,00 | Derivative Exercise and Retained Stock | - | 14,34k | 50,77% |
| 2025-12-29 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | -3,84k | 0,00 | Derivative Exercise and Sale | - | 14,34k | - |
| 2025-12-29 | Mr. Richard John DalyPresident, CEO & Director | 810,00 | 0,00 | Derivative Exercise and Retained Stock | - | 239,74k | 0,34% |
| 2025-12-29 | Mr. Richard John DalyPresident, CEO & Director | -524,00 | 0,00 | Derivative Exercise and Sale | - | 239,74k | - |
| 2025-12-29 | Mr. Donald A. DenkhausIndependent Director | 1,33k | 0,00 | Derivative Exercise and Retained Stock | - | 498,77k | 0,27% |
| 2025-12-29 | Mr. Brian ElsberndCCO & Chief Legal Officer | 4,04k | 0,00 | Derivative Exercise and Retained Stock | - | 242,50k | 1,70% |
| 2025-12-29 | Mr. Brian ElsberndCCO & Chief Legal Officer | -2,62k | 0,00 | Derivative Exercise and Sale | - | 242,50k | - |
| 2025-12-29 | Dr. Steven R. MillerExec. VP, COO & Chief Scientific Officer | 14,00k | 0,00 | Derivative Exercise and Retained Stock | - | 1,09M | 1,30% |
| 2025-12-29 | Ms. Molly HarperLead Independent Director | 1,33k | 0,00 | Derivative Exercise and Retained Stock | - | 3,69k | 56,53% |
| 2025-12-29 | Mr. Patrick J. McEnanyCo-Founder & Non-Executive Chairman | 19,55k | 0,00 | Derivative Exercise and Retained Stock | - | 4,17M | 0,47% |
| 2025-12-29 | Mr. Patrick J. McEnanyCo-Founder & Non-Executive Chairman | -6,79k | 0,00 | Derivative Exercise and Sale | - | 4,17M | - |
| 2025-12-29 | Dr. Preethi SundaramChief Strategy Officer | 4,30k | 0,00 | Derivative Exercise and Retained Stock | - | 54,80k | 8,51% |
| 2025-12-29 | Dr. Preethi SundaramChief Strategy Officer | -2,37k | 0,00 | Derivative Exercise and Sale | - | 54,80k | - |
| 2025-12-29 | Dr. David S. TierneyIndependent Director | 1,33k | 0,00 | Derivative Exercise and Retained Stock | - | 383,31k | 0,35% |
| 2025-12-12 | Ms. Molly HarperLead Independent Director | -20,00k | 350,76k | Derivative Exercise and Sale | 5,78 - 23,73 | 2,36k | - |
| 2025-12-12 | Ms. Molly HarperLead Independent Director | -6,75k | 155,56k | Verkauf | 23,06 | 2,36k | -74,08% |
| 2025-12-08 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | 5,55k | 0,00 | Derivative Exercise and Retained Stock | - | 9,51k | 140,01% |
| 2025-12-08 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | -2,49k | 0,00 | Derivative Exercise and Sale | - | 9,51k | - |
| 2025-12-08 | Mr. Donald A. DenkhausIndependent Director | 1,41k | 0,00 | Derivative Exercise and Retained Stock | - | 497,44k | 0,28% |
| 2025-12-08 | Ms. Molly HarperLead Independent Director | 1,41k | 0,00 | Derivative Exercise and Retained Stock | - | 9,11k | 18,37% |
| 2025-12-08 | Mr. Brian ElsberndCCO & Chief Legal Officer | 4,29k | 0,00 | Derivative Exercise and Retained Stock | - | 238,46k | 1,83% |
| 2025-12-08 | Mr. Brian ElsberndCCO & Chief Legal Officer | -2,78k | 0,00 | Derivative Exercise and Sale | - | 238,46k | - |
| 2025-12-08 | Mr. Patrick J. McEnanyCo-Founder & Non-Executive Chairman | 3,53k | 0,00 | Derivative Exercise and Retained Stock | - | 4,15M | 0,09% |
| 2025-12-08 | Dr. Preethi SundaramChief Strategy Officer | 5,19k | 0,00 | Derivative Exercise and Retained Stock | - | 50,51k | 11,44% |
| 2025-12-08 | Dr. Preethi SundaramChief Strategy Officer | -1,67k | 0,00 | Derivative Exercise and Sale | - | 50,51k | - |
| 2025-12-08 | Ms. Tamar ThompsonIndependent Director | 1,41k | 0,00 | Derivative Exercise and Retained Stock | - | 3,77k | 59,87% |
| 2025-12-08 | Dr. Steven R. MillerExec. VP, COO & Chief Scientific Officer | 11,87k | 0,00 | Derivative Exercise and Retained Stock | - | 1,08M | 1,11% |
| 2025-12-08 | Dr. David S. TierneyIndependent Director | 1,41k | 0,00 | Derivative Exercise and Retained Stock | - | 381,98k | 0,37% |
| 2025-12-01 | Mr. Patrick J. McEnanyCo-Founder & Non-Executive Chairman | -135,00k | 0,00 | Other Disposition | - | 4,15M | -3,15% |
| 2025-11-26 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | -10,98k | 210,01k | Derivative Exercise and Sale | 4,21 - 23,33 | 3,96k | - |
| 2025-11-21 | Mr. Michael W. KalbExec. VP, Treasurer & CFO | 4,41k | 0,00 | Derivative Exercise and Retained Stock | - | 8,61k | 105,05% |
| 2025-11-21 | Mr. Michael W. KalbExec. VP, Treasurer & CFO | -2,49k | 0,00 | Derivative Exercise and Sale | - | 8,61k | - |
| 2025-11-21 | Ms. Tamar ThompsonIndependent Director | 947,00 | 0,00 | Derivative Exercise and Retained Stock | - | 2,36k | 67,02% |
| 2025-11-21 | Dr. David S. TierneyIndependent Director | 947,00 | 0,00 | Derivative Exercise and Retained Stock | - | 380,57k | 0,25% |
| 2025-11-21 | Dr. Preethi SundaramChief Strategy Officer | 4,24k | 0,00 | Derivative Exercise and Retained Stock | - | 45,32k | 10,32% |
| 2025-11-21 | Dr. Preethi SundaramChief Strategy Officer | -1,36k | 0,00 | Derivative Exercise and Sale | - | 45,32k | - |
| 2025-11-21 | Dr. Steven R. MillerExec. VP, COO & Chief Scientific Officer | 8,27k | 0,00 | Derivative Exercise and Retained Stock | - | 1,07M | 0,78% |
| 2025-11-21 | Mr. Richard John DalyPresident, CEO & Director | 12,13k | 0,00 | Derivative Exercise and Retained Stock | - | 238,93k | 5,35% |
| 2025-11-21 | Mr. Richard John DalyPresident, CEO & Director | -7,87k | 0,00 | Derivative Exercise and Sale | - | 238,93k | - |
| 2025-11-21 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | 3,96k | 0,00 | Derivative Exercise and Retained Stock | - | 3,96k | - |
| 2025-11-21 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | -1,64k | 0,00 | Derivative Exercise and Sale | - | 3,96k | - |
| 2025-11-21 | Mr. Donald A. DenkhausIndependent Director | 947,00 | 0,00 | Derivative Exercise and Retained Stock | - | 496,03k | 0,19% |
| 2025-11-21 | Mr. Brian ElsberndCCO & Chief Legal Officer | 3,13k | 0,00 | Derivative Exercise and Retained Stock | - | 234,17k | 1,36% |
| 2025-11-21 | Mr. Brian ElsberndCCO & Chief Legal Officer | -2,03k | 0,00 | Derivative Exercise and Sale | - | 234,17k | - |
| 2025-11-21 | Ms. Molly HarperLead Independent Director | 947,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,69k | 14,04% |
| 2025-11-21 | Mr. Patrick J. McEnanyCo-Founder & Non-Executive Chairman | 1,78k | 0,00 | Derivative Exercise and Retained Stock | - | 4,28M | 0,04% |
| 2025-11-12 | Mr. Brian ElsberndCCO & Chief Legal Officer | -40,00k | 908,00k | Verkauf | 22,70 | 231,04k | -14,76% |
| 2025-09-08 | Mr. Brian ElsberndCCO & Chief Legal Officer | 82,48k | 184,74k | Derivative Exercise and Retained Stock | 2,24 | 271,04k | 43,74% |
| 2025-09-08 | Mr. Brian ElsberndCCO & Chief Legal Officer | -30,00k | 541,80k | Derivative Exercise and Sale | 2,24 - 20,30 | 271,04k | - |
| 2025-09-03 | Mr. Brian ElsberndCCO & Chief Legal Officer | -50,00k | 875,20k | Derivative Exercise and Sale | 2,24 - 20,08 | 188,56k | - |
| 2025-08-27 | Dr. David S. TierneyIndependent Director | 24,00k | 53,76k | Derivative Exercise and Retained Stock | 2,24 | 379,62k | 6,75% |
| 2025-08-27 | Dr. David S. TierneyIndependent Director | -26,00k | 466,96k | Derivative Exercise and Sale | 2,24 - 20,20 | 379,62k | - |
| 2025-08-26 | Mr. Richard John DalyPresident, CEO & Director | 27,03k | 60,55k | Derivative Exercise and Retained Stock | 2,24 | 226,79k | 13,53% |
| 2025-08-26 | Mr. Richard John DalyPresident, CEO & Director | -22,97k | 422,19k | Derivative Exercise and Sale | 2,24 - 20,62 | 226,79k | - |
| 2025-08-27 | Dr. Steven R. MillerExec. VP, COO & Chief Scientific Officer | 110,00k | 246,40k | Derivative Exercise and Retained Stock | 2,24 | 1,06M | 11,58% |
| 2025-08-26 | Dr. Steven R. MillerExec. VP, COO & Chief Scientific Officer | -115,00k | 2,07M | Derivative Exercise and Sale | 2,24 - 20,28 | 1,06M | - |
| 2025-06-10 | Dr. Preethi SundaramChief Strategy Officer | -3,92k | 103,65k | Verkauf | 26,41 - 26,42 | 41,08k | -8,72% |
| 2025-06-06 | Mr. Patrick J. McEnanyCo-Founder & Non-Executive Chairman | -200,00k | 5,22M | Verkauf | 25,95 - 26,11 | 4,28M | -4,46% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
